Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Nova Scotia’s top public health doctor says there have been 22 cases of heart inflammation reported in the province after immunization with Pfizer-BioNTech or Moderna COVID-19 vaccines.

The cases of myocarditis and pericarditis – or swelling of the heart muscle and lining – have mostly arisen in males between 20 and 30 years old who recently received their second doses of vaccine, Dr. Robert Strang, the province’s chief medical officer of health, told reporters on Friday.

It’s not clear what causes these conditions or if they are directly related to the vaccines, he said, adding that the events are rare and have been recorded across the globe.

Story continues below advertisement

“While the symptoms can be scary, people respond relatively quickly to conservative treatment and rest,” Strang said. “But the risk of remaining unimmunized far, far outweighs the risk from this uncommon and time-limited adverse effect.”

Moderna, Pfizer, AstraZeneca or Johnson & Johnson: Which COVID-19 vaccine will I get in Canada?

Everyone in Nova Scotia aged 12 and over should get a COVID-19 vaccine, he said.

Meanwhile, the province reported two new cases of COVID-19 Friday, for a total of 12 active reported cases. One of those infections involved a crew member of the HMCS Halifax, a Royal Canadian Navy frigate that docked in the province’s capital Monday after returning from a six-month deployment on the Mediterranean Sea. Strang said there are three cases confirmed among the ship’s crew.

As of Friday, 75 per cent of all people in Nova Scotia had received at least one dose of vaccine and 56 per cent had received two doses, according to online government data.

On Thursday, health officials reported that a woman in her 50s in the central zone died from COVID-19, marking the province’s 93rd death linked to the novel coronavirus. Strang said Friday the woman was not immunized.

The province’s mass vaccination clinics will begin to wind down Aug. 15, but pharmacies will continue to administer shots throughout the summer and into the fall, Strang said. The Health Department, he added, is working with pharmacies to ensure there is plenty of access to vaccines once the clinics close.

Strang acknowledged that vaccination rates are lowest among younger people, but said that was expected and rates are still higher for younger age groups in Nova Scotia than they are among youth in other parts of the country. He said he didn’t think that closing mass vaccination clinics would deter younger people from getting a shot.

Story continues below advertisement

“And we are getting 1,000 or more people a day for first doses, most of whom are in those younger age groups,” he said. “So we will get there, it’s going to take a little bit more time.”

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies